F
$ Value
$13.0M
Shares
28,173
Price
$460
Filed
Nov 4
Insider
Name
HAZEN SAMUEL N
Title
CEO
CIK
0001216838
Roles
Director
Officer
Transaction Details
Transaction Date
2025-10-31
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
47,106
Footnotes
The stock appreciation rights vested in four equal annual installments beginning on January 29, 2017.
Filing Info
HAZEN SAMUEL N's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-10 | HCA | A | $0 |
| 2026-02-10 | HCA | F | $10.7M |
| 2026-02-04 | HCA | J | $521K |
| 2026-02-04 | HCA | J | $521K |
| 2026-02-03 | HCA | ▼ | $7.4M |
| 2026-02-03 | HCA | ▼ | $2.5M |
| 2026-02-03 | HCA | ▼ | $3.7M |
| 2026-02-03 | HCA | ▼ | $3.1M |
| 2026-02-03 | HCA | ▼ | $2.6M |
| 2026-02-03 | HCA | ▼ | $2.1M |
Other Insiders at HCA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| FRIST THOMAS F JR | — | — | 2026-02-06 |
|
HAZEN SAMUEL N
CEO
|
— | $21.5M | 2026-02-10 |
| FRIST THOMAS F III | — | — | 2026-02-06 |
| HERCULES HOLDING II | — | — | 2026-02-06 |
| Frisco Holding II | — | — | 2026-02-06 |
| Elcan Patricia F | — | — | 2026-02-06 |
| Frist William R | — | — | 2026-02-06 |
|
Foster Jon M
EVP and COO
|
— | — | 2026-02-10 |
|
Cuffe Michael S.
EVP and Chief Clinical Officer
|
— | $747K | 2026-02-10 |
|
Wyatt Christopher F.
SVP & Controller
|
— | $2.0M | 2026-02-11 |
|
Berres Jennifer
SVP & Chief Human Res. Officer
|
— | $4.1M | 2026-02-11 |
|
McAlevey Michael R
EVP & Chief Legal & Admin Off.
|
— | $904K | 2026-02-18 |
|
Marks Mike A
EVP and CFO
|
— | — | 2026-02-10 |
|
Rossitto Erica
SVP & Chief Nurse Executive
|
— | — | 2026-02-10 |